Julia Katherine

Metastatic Thriver/Advocate Lead Research Advocate and Publications/Clinical Trial Curator, Writer, Lobular Breast Cancer Alliance @LobularBCA Tweets are my own

[Julia Katherine @jackel626]

Awesome talk @oesterreichs !!!❤️

[AACR @AACR]

Steffi Oesterreich delivered the AACR Distinguished Lecture in Breast Cancer Research (supported by Aflac, Inc.) today at #SABCS24. She was recognized for her contributions in translational breast cancer research that have advanced our understanding of invasive lobular carcinoma.

[Julia Katherine @jackel626]

@JaniceTNBCmets @amybeumer Agree with @amybeumer -xelod so much easier than enhertu.

[Julia Katherine @jackel626]

@stacy_hurt Congratulations!!

[Julia Katherine @jackel626]

Congratulations to our #Lobmom @oesterreichs ! #Lobmob is so proud. Amazing to see ILC in the spotlight. W'eve come a long way baby!

[AACR @AACR]

Congratulations to Steffi Oesterreich, PhD, this year’s recipient of the AACR Distinguished Lectureship in Breast Cancer Research. Dr. Oesterreich will present her award lecture at #SABCS24 on December 12. https://t.co/3dQzPmGVrj @UPMCHillmanCC @SABCSSanAntonio

[Jason A. Mouabbi MD @JAMouabbi]

🚨 Exciting news! 🚨 #SABCS24 is almost here, and I'm thrilled to share that 50 #ILC #Lobular abstracts will be presented this year! 📚✨

This is a major milestone—just a few years ago, we barely saw single-digit numbers. The progress is incredible!

Huge kudos to @LobularBCA, @elbcc, @LobularBCUK, and @LobularIreland for championing this progress! 👏👏👏

@SABCSSanAntonio @AACR @OncoAlert @oncodaily

[Matt Covington, MD @MFCovington]

Invasive #LobularCarcinoma, the 2nd most common #breastcancer subtype, is harder to detect and monitor than invasive ductal carcinoma. Despite being less researched, #ILC takes center stage at the #ILCsymposium, along with the incredible attendees I’ve met.

[Julia Katherine @jackel626]

@MFCovington Great meeting you!

[Gitte Joergensen @GitteJoergensen]

Dinner with the #lobmob at the #ILCsymposium @faceofstage4 @lobbccanada @jackel626 @lbhutcheson @CancerSuckLess 🦞🦞🦞#MakeCancerLessShitty is now in Belgium 🇧🇪 and boy do we talk about side effects 🤪

[Christine Desmedt @ChristineDesme2]

Co-organization and great interactions with patient advocates ☺️ @LobularBCUK @LobularBCA @lobbccanada @LobularIreland @hiplinemedia @tonelien @GRASPtweets @TanjaSpanic @jackel626

[Christine Desmedt @ChristineDesme2]

Don't forget to register for the ILC Symposium 2024 (only 40 seats still available)! Deadline abstract submission extended to 24th of August. @oncoalert @elbcc @PWBDerksen @aftimosp @oesterreichs @AVincentSalomon @LobularBCUK @LobularIreland @LobularBCA https://t.co/kBqV5sOMt5

[Julia Katherine @jackel626]

@PeteSim10031537 @breast_lab @UQMedicine @UQ_News Congratulations! And thank you for moving ILC research forward!

[Julia Katherine @jackel626]

@Dr_RShatsky @UCSDCancer @cure_today Excellent article! I will post in my fb groups!

[Julia Katherine @jackel626]

@ElisaAgostinett @JLSandoval @Alfdoc2 @Timothee_MD It would be interesting to know if any of the ER+ "Flippers" who have lost their receptor status responded. That data may not be there. @Dr_RShatsky

[Julia Katherine @jackel626]

@jillfeldman4 Yes!

[Julia Katherine @jackel626]

@HBatraSharmaMD @LudaBazhenovaMD @IdaWongMD1 @Dr_RShatsky @HBatraSharmaMD When are you ending your residency? ill be seeing Dr S July 11. Best of luck in your next endeavor and hopefully we will continue to work together 😊

[Julia Katherine @jackel626]

@Dr_RShatsky You were excellent!🥰

[Julia Katherine @jackel626]

@JAMouabbi @BostonGeneCorp @MDAndersonNews @OncoAlert @GRASPtweets Congratulations! Ill be at the GRASP session!

[Julia Katherine @jackel626]

@amybeumer It doesnt seem to be a priority here in L.A. its been hard to find. Not even nurse practioners available. I hope this changes things.

[Julia Katherine @jackel626]

@Dr_RShatsky @ER_OncDoc @ASCO Wishing you a luck and a great anniversary! I know youll give a great presentation. Is it online to watch later ?-sorry not getting up at 6 am💤 ❤️❤️